
Altos Labs: Senolytic Insolvency
Cassandra saw the ashes before the fire. Altos Labs called it reprogramming; we just see the rust beneath the billions. This episode plunges into the multi-billion dollar promise of "healthspan," where our auditors, Katie and Marcus, dissect the forensic metrics of Altos Labs' ambitious epigenetic reprogramming initiatives. Marcus, ever the cynic, views the venture as mere "painting over rust" – a gilded cage for the elite desperate to outrun mortality. Katie, grounded in data, meticulously charts their Q1 2026 milestones, revealing nascent achievements in reducing biological age markers, yet…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.